[
  {
    "ts": null,
    "headline": "Workday Announces Fiscal 2026 Fourth Quarter and Full Year Financial Results",
    "summary": "Workday, Inc. (NASDAQ: WDAY), the enterprise AI platform for managing people, money, and agents, today announced results for the fiscal 2026 fourth quarter and full year ended January 31, 2026.",
    "url": "https://finnhub.io/api/news?id=fa757669b84f3e69d62a1895854de88a159718b94b566b4ea1c3073a7c05cc7d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771966860,
      "headline": "Workday Announces Fiscal 2026 Fourth Quarter and Full Year Financial Results",
      "id": 139201614,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Workday, Inc. (NASDAQ: WDAY), the enterprise AI platform for managing people, money, and agents, today announced results for the fiscal 2026 fourth quarter and full year ended January 31, 2026.",
      "url": "https://finnhub.io/api/news?id=fa757669b84f3e69d62a1895854de88a159718b94b566b4ea1c3073a7c05cc7d"
    }
  },
  {
    "ts": null,
    "headline": "SMMT Incurs Wider-Than-Expected Q4 Loss, Pipeline Progress in Focus",
    "summary": "Summit Therapeutics posts a wider Q4 loss as R&D spending surges. Its ivonescimab pipeline advances with a BLA filing and multiple late-stage cancer trials underway.",
    "url": "https://finnhub.io/api/news?id=71bdd09f99f288cdf642973b100f7ae41b44ab473d2306d4d06c953e62058394",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771950660,
      "headline": "SMMT Incurs Wider-Than-Expected Q4 Loss, Pipeline Progress in Focus",
      "id": 139200923,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Summit Therapeutics posts a wider Q4 loss as R&D spending surges. Its ivonescimab pipeline advances with a BLA filing and multiple late-stage cancer trials underway.",
      "url": "https://finnhub.io/api/news?id=71bdd09f99f288cdf642973b100f7ae41b44ab473d2306d4d06c953e62058394"
    }
  },
  {
    "ts": null,
    "headline": "How Is Merck & Co.'s Stock Performance Compared to Other Healthcare Stocks?",
    "summary": "Despite Merck & Co.’s strong performance relative to its peers over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects",
    "url": "https://finnhub.io/api/news?id=974b5e7ab3d8f6cf174435a22653bdfb823ca8acd138c76e3d9291d781cf0820",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771949063,
      "headline": "How Is Merck & Co.'s Stock Performance Compared to Other Healthcare Stocks?",
      "id": 139200924,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Despite Merck & Co.’s strong performance relative to its peers over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects",
      "url": "https://finnhub.io/api/news?id=974b5e7ab3d8f6cf174435a22653bdfb823ca8acd138c76e3d9291d781cf0820"
    }
  },
  {
    "ts": null,
    "headline": "MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal",
    "summary": "MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal",
    "url": "https://finnhub.io/api/news?id=96be40d5268f9b8e59031cf300e9e46c0da0004e252dc659344a52e5fade5827",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771941012,
      "headline": "MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal",
      "id": 139199577,
      "image": "",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=96be40d5268f9b8e59031cf300e9e46c0da0004e252dc659344a52e5fade5827"
    }
  },
  {
    "ts": null,
    "headline": "Merck to Participate in the TD Cowen 46th Annual Health Care Conference",
    "summary": "RAHWAY, N.J., February 24, 2026--Merck to Participate in the TD Cowen 46th Annual Health Care Conference",
    "url": "https://finnhub.io/api/news?id=0233c468b2fb9a58a9850ac523a879ac0017c74d4cbe0371494973d68bc4ae12",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771933500,
      "headline": "Merck to Participate in the TD Cowen 46th Annual Health Care Conference",
      "id": 139193263,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "RAHWAY, N.J., February 24, 2026--Merck to Participate in the TD Cowen 46th Annual Health Care Conference",
      "url": "https://finnhub.io/api/news?id=0233c468b2fb9a58a9850ac523a879ac0017c74d4cbe0371494973d68bc4ae12"
    }
  },
  {
    "ts": null,
    "headline": "Amazon, Merck, PG&E And More On CNBC's 'Final Trades'",
    "summary": "Amazon invests $12 billion in data centers in Louisiana, Merck &amp; Co., Inc. receives positive coverage, and Horizon Kinetics Inflation Beneficiaries ETF shows slight growth.",
    "url": "https://finnhub.io/api/news?id=4dfb146317a538c206afff7614c7f7d580866ed8900cf8c3e9940ffc700ce6ae",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771925163,
      "headline": "Amazon, Merck, PG&E And More On CNBC's 'Final Trades'",
      "id": 139194745,
      "image": "https://cdn.benzinga.com/files/images/story/2026/02/24/Crypto-Trader-Investor-Broker-Using-Smar.jpeg?width=2048&height=1536",
      "related": "MRK",
      "source": "Benzinga",
      "summary": "Amazon invests $12 billion in data centers in Louisiana, Merck &amp; Co., Inc. receives positive coverage, and Horizon Kinetics Inflation Beneficiaries ETF shows slight growth.",
      "url": "https://finnhub.io/api/news?id=4dfb146317a538c206afff7614c7f7d580866ed8900cf8c3e9940ffc700ce6ae"
    }
  },
  {
    "ts": null,
    "headline": "Merck (MRK) Announces Positive Phase 3 SMART Trial Results for ENFLONSIA (Clesrovimab)",
    "summary": "Merck & Co. Inc. (NYSE:MRK) is one of the best value stocks to buy now. On February 19, Merck announced positive second-season findings from the Phase 3 SMART trial evaluating ENFLONSIA (clesrovimab) in infants and children under 2 years of age at increased risk for severe respiratory syncytial virus/RSV. The data focused on vulnerable children, […]",
    "url": "https://finnhub.io/api/news?id=c0f0cedf564b5fbe1a99e5d6d9af06ecf703107cc66f56e3a56db98d3d4cfc2b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771917074,
      "headline": "Merck (MRK) Announces Positive Phase 3 SMART Trial Results for ENFLONSIA (Clesrovimab)",
      "id": 139191734,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck & Co. Inc. (NYSE:MRK) is one of the best value stocks to buy now. On February 19, Merck announced positive second-season findings from the Phase 3 SMART trial evaluating ENFLONSIA (clesrovimab) in infants and children under 2 years of age at increased risk for severe respiratory syncytial virus/RSV. The data focused on vulnerable children, […]",
      "url": "https://finnhub.io/api/news?id=c0f0cedf564b5fbe1a99e5d6d9af06ecf703107cc66f56e3a56db98d3d4cfc2b"
    }
  },
  {
    "ts": null,
    "headline": "Russia's war on Ukraine puts women off having children — and that could spell economic disaster",
    "summary": "Four years of war have discouraged Ukrainian and Russian women from having children, and that could impact their economies in the future.",
    "url": "https://finnhub.io/api/news?id=53795300e06e0d4454e6b04b451c0e619690754126ab2762ed8dab8647314a9d",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771895025,
      "headline": "Russia's war on Ukraine puts women off having children — and that could spell economic disaster ",
      "id": 139198069,
      "image": "https://image.cnbcfm.com/api/v1/image/108268945-1771917055711-gettyimages-1583281302-uk_20230807_ukr61.jpeg?v=1771917103&w=1920&h=1080",
      "related": "MRK",
      "source": "CNBC",
      "summary": "Four years of war have discouraged Ukrainian and Russian women from having children, and that could impact their economies in the future.",
      "url": "https://finnhub.io/api/news?id=53795300e06e0d4454e6b04b451c0e619690754126ab2762ed8dab8647314a9d"
    }
  }
]